{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T12:27:53Z","timestamp":1786883273816,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK099442"],"award-info":[{"award-number":["K23DK099442"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK087726"],"award-info":[{"award-number":["R01DK087726"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011751","name":"Northwest Kidney Centers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL157535"],"award-info":[{"award-number":["R01HL157535"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001860"],"award-info":[{"award-number":["UL1TR001860"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jacl.2026.05.225","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:56:44Z","timestamp":1779429404000},"page":"1417-1429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipoprotein(a) lipidome and chronic kidney disease: Enrichment in triacylglycerols and diacylglycerols"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4588-8670","authenticated-orcid":false,"given":"Muhammad A.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0279-4574","authenticated-orcid":false,"given":"Munkhtuya","family":"Myagmarsuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9830-1048","authenticated-orcid":false,"given":"Hayley G.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baback","family":"Roshanravan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heejung","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Fiehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1571-7592","authenticated-orcid":false,"given":"Ian H.","family":"De Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6705-1791","authenticated-orcid":false,"given":"Lars","family":"Berglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byambaa","family":"Enkhmaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2026.05.225_bib1","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","article-title":"Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2026.05.225_bib2","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2026.05.225_bib3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1172\/JCI115855","article-title":"Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations","volume":"90","author":"Boerwinkle","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2026.05.225_bib4","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jacc.2009.10.080","article-title":"Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants","volume":"55","author":"Erqou","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2026.05.225_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2022.04.006","article-title":"Non-genetic influences on lipoprotein(a) concentrations","volume":"349","author":"Enkhmaa","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.05.225_bib6","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s10157-013-0875-8","article-title":"Causes and consequences of lipoprotein(a) abnormalities in kidney disease","volume":"18","author":"Kronenberg","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jacl.2026.05.225_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1194\/jlr.R083626","article-title":"The role of lipoprotein(a) in chronic kidney disease","volume":"59","author":"Hopewell","year":"2018","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.05.225_bib8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.ejhg.5201016","article-title":"Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation","volume":"11","author":"Kronenberg","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jacl.2026.05.225_bib9","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","article-title":"Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease","volume":"18","author":"Matsushita","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jacl.2026.05.225_bib10","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s40620-023-01590-3","article-title":"Relationship between lipoprotein(a) levels, cardiovascular outcomes and death in patients with chronic kidney disease: a systematic review of prospective studies","volume":"36","author":"Barbagelata","year":"2023","journal-title":"J Nephrol"},{"key":"10.1016\/j.jacl.2026.05.225_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1194\/jlr.R800074-JLR200","article-title":"The role of oxidized phospholipids in atherosclerosis","volume":"50","author":"Berliner","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.05.225_bib12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MOL.0b013e328308b622","article-title":"The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity","volume":"19","author":"Tsimikas","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2026.05.225_bib13","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1194\/jlr.M800174-JLR200","article-title":"A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma","volume":"49","author":"Bergmark","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.05.225_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020158","article-title":"Lp(a)-associated oxidized phospholipids in healthy black and white participants in relation to apo(a) size, age, and family structure","volume":"10","author":"Berglund","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacl.2026.05.225_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41581-021-00488-2","article-title":"Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease","volume":"18","author":"Baek","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jacl.2026.05.225_bib16","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.113.002500","article-title":"Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study","volume":"129","author":"Stegemann","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.05.225_bib17","doi-asserted-by":"crossref","first-page":"16394","DOI":"10.1038\/s41598-022-20757-9","article-title":"Lipidic profiles of patients starting peritoneal dialysis suggest an increased cardiovascular risk beyond classical dyslipidemia biomarkers","volume":"12","author":"Lluesa","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacl.2026.05.225_bib18","doi-asserted-by":"crossref","first-page":"e122219","DOI":"10.1172\/jci.insight.122219","article-title":"Chronic kidney disease attenuates the plasma metabolome response to insulin","volume":"16","author":"Roshanravan","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacl.2026.05.225_bib19","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1681\/ASN.2015070756","article-title":"Impaired glucose and insulin homeostasis in moderate-severe CKD","volume":"27","author":"de Boer","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jacl.2026.05.225_bib20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/ndt\/gfw425","article-title":"Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C","volume":"32","author":"Pottel","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacl.2026.05.225_bib21","first-page":"1063","article-title":"Expressed hypervariable polymorphism of apolipoprotein(a)","volume":"49","author":"Kamboh","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacl.2026.05.225_bib22","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1194\/jlr.P091249","article-title":"Heritability of apolipoprotein (a) traits in two-generational African-American and Caucasian families","volume":"60","author":"Enkhmaa","year":"2019","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.05.225_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1007079223546","article-title":"Evaluation of a new apolipoprotein(a) isoform-independent assay for serum lipoprotein(a)","volume":"207","author":"Dembinski","year":"2000","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jacl.2026.05.225_bib24","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/clinchem\/44.8.1629","article-title":"International Federation of Clinical Chemistry standardization project for the measurement of lipoprotein(a). Phase I. Evaluation of the analytical performance of lipoprotein(a) assay systems and commercial calibrators","volume":"44","author":"Tate","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2026.05.225_bib25","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1194\/jlr.M500359-JLR200","article-title":"Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo[a]","volume":"47","author":"Rubin","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.05.225_bib26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1194\/jlr.M600431-JLR200","article-title":"ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Study","volume":"48","author":"Anuurad","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.05.225_bib27","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.3390\/nu17193113","article-title":"Lipoprotein(a) lipidome: responses to reduced dietary saturated fat intake in two randomized controlled feeding trials","volume":"17","author":"Myagmarsuren","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.jacl.2026.05.225_bib28","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1194\/jlr.M040733","article-title":"Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a)","volume":"54","author":"Leibundgut","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.05.225_bib29","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1194\/jlr.M005769","article-title":"Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet","volume":"51","author":"Faghihnia","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.05.225_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.metabol.2015.10.031","article-title":"Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a)","volume":"65","author":"Diffenderfer","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2026.05.225_bib31","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/CIRCULATIONAHA.116.020838","article-title":"Oxidized phospholipids on lipoprotein(a) elicit arterial wall inflammation and an inflammatory monocyte response in humans","volume":"134","author":"van der Valk","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.05.225_bib32","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/s41592-021-01331-z","article-title":"Spectral entropy outperforms MS\/MS dot product similarity for small-molecule compound identification","volume":"18","author":"Li","year":"2021","journal-title":"Nat Methods"},{"key":"10.1016\/j.jacl.2026.05.225_bib33","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/ng1032","article-title":"Microarray data normalization and transformation","volume":"32","author":"Quackenbush","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacl.2026.05.225_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R\u00a0Stat Soc B"},{"key":"10.1016\/j.jacl.2026.05.225_bib35","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1161\/ATVBAHA.117.309920","article-title":"Lipoprotein(a) and risk of myocardial infarction and death in chronic kidney disease: findings from the CRIC study (Chronic Renal Insufficiency Cohort)","volume":"37","author":"Bajaj","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2026.05.225_bib36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.atherosclerosis.2017.06.916","article-title":"Deuterium-reinforced polyunsaturated fatty acids protect against atherosclerosis by lowering lipid peroxidation and hypercholesterolemia","volume":"264","author":"Berbee","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.05.225_bib37","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1007\/s11357-024-01453-0","article-title":"Plasma triacylglycerol length and saturation level mark healthy aging groups in humans","volume":"47","author":"Li","year":"2025","journal-title":"Geroscience"},{"key":"10.1016\/j.jacl.2026.05.225_bib38","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/ATVBAHA.123.319937","article-title":"Diacylglycerols and lysophosphatidic acid, enriched on lipoprotein(a), contribute to monocyte inflammation","volume":"44","author":"Dzobo","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2026.05.225_bib39","doi-asserted-by":"crossref","first-page":"E990","DOI":"10.1152\/ajpendo.00602.2014","article-title":"Long-chain acylcarnitines activate cell stress and myokine release in C2C12 myotubes: calcium-dependent and -independent effects","volume":"308","author":"McCoin","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jacl.2026.05.225_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.975176","article-title":"Phosphatidylserine, inflammation, and central nervous system diseases","volume":"14","author":"Ma","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.jacl.2026.05.225_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/mas.21659","article-title":"Recognition and avoidance of ion source-generated artifacts in lipidomics analysis","volume":"41","author":"Hu","year":"2022","journal-title":"Mass Spectrom Rev"},{"key":"10.1016\/j.jacl.2026.05.225_bib42","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1016\/j.jacl.2024.03.001","article-title":"A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice","volume":"18","author":"Koschinsky","year":"2024","journal-title":"J Clinic Lipidol"},{"key":"10.1016\/j.jacl.2026.05.225_bib43","article-title":"Lipoprotein(a) and CKD: insights into new therapeutic opportunities","author":"Enkhmaa","year":"2025","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426003636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426003636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T11:30:30Z","timestamp":1786879830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287426003636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1933287426003636"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.05.225","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein(a) lipidome and chronic kidney disease: Enrichment in triacylglycerols and diacylglycerols","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.05.225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}